ADC Vaccine

PreclinicalVaccine

IInstituto Oncológico Dr Rosell

ADC Vaccine is one of 45 biologic programs targeting Lung Cancer. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Lung CancerActive, not recruiting

Extensive-Stage Small-Cell Lung CancerCompleted

Lung CancerPhase 1/Phase 2

Active, not recruiting

Extensive-Stage Small-Cell Lung CancerPreclinical

Completed

Competition

Competitive Landscape

686 competitors in Lung Cancer

#DrugCompanyPhaseTrials

Tecentriq

Roche

Preclinical

9 2

Libtayo

Regeneron

Preclinical

3 3

Vizimpro

Pfizer

Preclinical

3 4

Talzenna

Pfizer

Preclinical

2 5

Folvite

Xylocaine

2 7

Immunotherapy

Bristol-Myers Squibb

Preclinical

5 8

Paclitaxel and Carboplatin

Bristol-Myers Squibb

Preclinical

2 9

Rilotumumab

Amgen

Preclinical

2 10

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Preclinical

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Extensive-stage Small-cell Lung Cancer1 trial

Phase Ib/II Trial of the Combination of Atezolizumab With Dendritic Cell Vaccination as Maintenance Treatment in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) After Induction Treatment

Completed·IInstituto Oncológico Dr Rosell·Preclinical·NCT04487756·20 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for ADC Vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — ADC Vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for ADC Vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Instituto Oncológico Dr Rosell company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Preclinical[1]
Company: IInstituto Oncológico Dr Rosell

ADC Vaccine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Extensive-stage Small-cell Lung Cancer1 trial

References

Drug Info

Quick Facts

Related News